Infuse patients target Medtronic, but legal hurdles abound

A U.S. Appeals Court rejected a patient's attempt to sue Medtronic for an "off-label" use of the bone-growth product, ruling that a suit wasn't allowed under federal law...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.